Are You Leveraging Key Opinion Leaders for Biopharma Market Access As Much As You Could Be?

For biopharma market access teams, engaging KOLs who help structure guidelines and downstream payer polices may be a high impact but untapped resource.

Read Full Byline in Cell & Gene

For biopharmaceutical manufacturers considering pre-launch key opinion leader (KOL) engagement strategies, broadening your payer strategy to include network mapping will help you reach the clinical experts who help evaluate and shape guidelines and policies. This targeted approach, done in parallel to medical affairs provider outreach, is essential to optimize patient access.

Kathryne Kirk, Meghan Cioci, and Matthew Franceschini examine how network mapping analysis and tailoring outreach efforts can help these influencers gain access to compelling evidence and insights.

Read the full byline.

Back to top